News

On May 1st, Dr. Ivy Gao, Chairman of the Board Sunresin, was granted 2024 Labor Medal by province government.

Sunresin is transforming pharmaceutical formulations with its innovative medicinal powder resins. These water-insoluble polymers feature a unique mesh-like structure capable of exchanging ions with those in a solution.

In the complex world of wastewater management, high-salinity wastewater poses a unique set of challenges. With its mix of inorganic ions and organic substances, traditional treatment methods often fall short. But at Sunresin, we're changing the game.

On the evening of April 21, Sunresin(300487.SZ)disclosed its annual report for 2023. In 2023, the company realized operating revenue of $350.5 million, up 29.6% YoY; realized net profit attributable to shareholders of $101.6 million, up 33.4% YoY. Revenue and net profit both hit record highs in 2023.

Sunresin has been at the forefront of transitioning sugar refineries from traditional whitening methods to our state-of-the-art ion exchange decolorization technology.

Summary of the Sunresin 2024 Q1 Report

In April, Ambassador Xu Yicong's book launch of "Family and Country Sentiments - Continuing Chapter" was successfully held in Beijing. The ambassadors of Latin America in China have come to congratulate Ambassador Xu, and Zhai Feng, Vice President of Bump Cycle, attended to celebrate the event. Dr. Gao Yuejing, as the representative of the important guests, gave a speech and expressed her most sincere blessing to Ambassador Xu for the publication of his new book.

Sunresin is leading the charge with our innovative XDA series resins, specifically designed to tackle the toughest pyridine wastewater treatment challenges.